A PSMA PET scan looks for prostate cancer that spreads in the body. This imaging test also can detect cancer that comes back and help with choosing a treatment.
Prostate cancer that spreads
A PSMA PET scan is sometimes used when prostate cancer is first diagnosed. It might be used if there's a risk that prostate cancer has spread beyond the prostate. Prostate cancer that spreads is called metastatic prostate cancer. It also is called stage 4 prostate cancer. Most people with prostate cancer have cancer only in the prostate, so they don't need this test.
A PSMA PET scan is one of many tests that can look for signs that the cancer has spread. Other imaging tests include bone scans, CT scans, MRI scans and other types of PET scans.
The test or combination of tests that is best for you depends on your situation. To choose a test, your healthcare team considers your overall health, your symptoms and the results of tests on your cancer cells. The care team also might consider which tests are available in your area. Not every hospital has every test. In the United States, the choice of test also might depend on which ones your health insurance covers.
Prostate cancer that comes back after treatment
If you had treatment for prostate cancer and have signs that the cancer is back, a PSMA PET scan might be used to look for the cancer. Prostate cancer that comes back after treatment is called recurrent prostate cancer.
Often a rising level of prostate-specific antigen, also called PSA, in the blood is the first sign of recurrent prostate cancer. If a blood test shows elevated PSA levels, your healthcare professional might recommend imaging tests to look for the cancer.
Imaging tests might look for signs of recurrent prostate cancer near the prostate or where the prostate used to be if it was removed with surgery. Often the imaging test is an MRI scan of the pelvis.
Some tests look for prostate cancer in the bones. Examples of tests that look for cancer only in the bones include a bone scan and a sodium fluoride F-18 PET scan.
Other tests look for prostate cancer all over the body. These tests include the PSMA PET scan and other PET scans, such as the choline C-11 PET scan, fluciclovine F-18 PET scan, and fluorodeoxyglucose F-18 PET scan, also called FDG PET scan.
There are many imaging tests that can help detect recurrent prostate cancer. To pick a test, your healthcare team considers your PSA levels, your symptoms, your overall health and which prostate cancer treatments you had. Your care team also might consider what tests are available in your area and which tests your insurance covers.
Prostate cancer treatment
The results of a PSMA PET scan can help the healthcare team decide on a treatment. The results might be used to decide on treatment for a metastatic prostate cancer that no longer responds to hormone therapy treatment. This kind of prostate cancer is sometimes called metastatic castration-resistant prostate cancer.
If a PSMA PET scan shows that the tracer builds up in the prostate cancer cells, this is a sign that treatment with PSMA therapy may help treat the cancer. If the tracer doesn't build up in the cancer cells, then PSMA therapy isn't likely to treat the cancer.
PSMA therapy uses a medicine that contains a substance that finds and sticks to the PSMA on prostate cancer cells. The medicine also contains a radioactive substance that can kill cancer cells. A healthcare professional gives this medicine through a vein. The medicine finds prostate cancer cells and releases radiation directly into the cells.